600
Participants
Start Date
December 31, 2004
Study Completion Date
October 31, 2005
ATL-962
Orlistat
Turku University Hospital, Turku
Lääkärikeskus Minerva, Eura
Suomen Terveystalo, Jyväskylä
Oulun Diakonissalaitos, Oulu
Aalborg Sygehus Nord, Aalborg
Odense University Hospital, Odense
Oy Foodfiles Limited, Kuopio
University of Oulu, Oulu
Allevon, Den Bosch Ziekenhuis
Allevon, DN de Bilt
Zeikenhuisgroep Twente, Hengelo
Nederlandse Obesitas Klinik, Hilversum
Sint Franciscus Gasthuis, Rotterdam
Sahlgrenska University Hospital, Gothenburg
Linkoping University Hospital, Linköping
Karolinsaka University Hospital, Stockholm
Norrlands Universitetssjukhus, Umeå
Samariterhemmets Sjukhus, Uppsala
Aberdeen Royal Infirmary, Aberdeen
Royal United Hospital, Bath
Clinical Research Centre Edgbaston, Birmingham
Walsgrave Hospital, Coventry
Glasgow Royal Infirmary, Glasgow
Clinical Research Centre, Crosby, Liverpool
Liverpool University Hospital, Liverpool
Hammersmith Hospital, London
Luton & Dunstable Hospital, Luton
Clinical Research Centre, Manchester
James Cook University Hospital, Middlesbrough
Royal Shrewsbury Hospital, Shrewsbury
Clinical Research Centre, Wigan
Aarhus University Hospital, Aarhus
Bispebjerg Hospital, Copenhagen
Gentofte Hospital, Hellerup
Hvidovre Hospital, Hvidovre
Obesity Research Unit, Helsinki
Queen Mary's School of Medicine & Dentistry, London
Lead Sponsor
Alizyme
INDUSTRY